Who are Metolazone concurrently with furosemide's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/metolazone-concurrently-with-furosemide.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Metolazone concurrently with furosemide — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Metolazone concurrently with furosemide (Metolazone concurrently with furosemide) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Thiazide-like diuretic and loop diuretic combination. Area: Cardiovascular.

marketed Thiazide-like diuretic and loop diuretic combination Sodium-chloride cotransporter (NCC) and sodium-potassium-chloride cotransporter (NKCC2) Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Metolazone concurrently with furosemide (Metolazone concurrently with furosemide) — University of Maryland, Baltimore. Metolazone and furosemide together act as synergistic diuretics that block sodium reabsorption at different nephron sites to produce enhanced fluid and electrolyte excretion.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Metolazone concurrently with furosemide TARGET	Metolazone concurrently with furosemide	University of Maryland, Baltimore	marketed	Thiazide-like diuretic and loop diuretic combination	Sodium-chloride cotransporter (NCC) and sodium-potassium-chloride cotransporter (NKCC2)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Thiazide-like diuretic and loop diuretic combination class)

University of Maryland, Baltimore · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Metolazone concurrently with furosemide — Competitive Intelligence Brief. https://druglandscape.com/ci/metolazone-concurrently-with-furosemide. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab